Published in J Neurosci Res on June 01, 2010
Innate immunity in the central nervous system. J Clin Invest (2012) 2.77
IL-1β production through the NLRP3 inflammasome by hepatic macrophages links hepatitis C virus infection with liver inflammation and disease. PLoS Pathog (2013) 1.67
The pathology of an autoimmune astrocytopathy: lessons learned from neuromyelitis optica. Brain Pathol (2014) 1.60
The adverse effects of air pollution on the nervous system. J Toxicol (2012) 1.28
Inflammasomes in neuroinflammation and changes in brain function: a focused review. Front Neurosci (2014) 1.26
Post-ischemic inflammation in the brain. Front Immunol (2012) 1.18
Alcohol-induced IL-1β in the brain is mediated by NLRP3/ASC inflammasome activation that amplifies neuroinflammation. J Leukoc Biol (2013) 1.10
Genetic ablation of Pannexin1 protects retinal neurons from ischemic injury. PLoS One (2012) 1.10
Caspase-8 promotes NLRP1/NLRP3 inflammasome activation and IL-1β production in acute glaucoma. Proc Natl Acad Sci U S A (2014) 1.07
Inflammasome-IL-1β Signaling Mediates Ethanol Inhibition of Hippocampal Neurogenesis. Front Neurosci (2012) 1.06
Focal brain inflammation and autism. J Neuroinflammation (2013) 1.03
Molecular mechanisms of liver fibrosis in HIV/HCV coinfection. Int J Mol Sci (2014) 1.01
NLRP3 inflammasome: key mediator of neuroinflammation in murine Japanese encephalitis. PLoS One (2012) 1.01
Interleukin-33 upregulation in peripheral leukocytes and CNS of multiple sclerosis patients. Clin Immunol (2011) 1.01
Interleukin-1β induces blood-brain barrier disruption by downregulating Sonic hedgehog in astrocytes. PLoS One (2014) 1.00
Mast cells, glia and neuroinflammation: partners in crime? Immunology (2014) 0.99
Brain "fog," inflammation and obesity: key aspects of neuropsychiatric disorders improved by luteolin. Front Neurosci (2015) 0.99
An astrocyte-specific proteomic approach to inflammatory responses in experimental rat glaucoma. Invest Ophthalmol Vis Sci (2012) 0.97
The role of inflammasome in Alzheimer's disease. Ageing Res Rev (2014) 0.95
Mast cell-glia axis in neuroinflammation and therapeutic potential of the anandamide congener palmitoylethanolamide. Philos Trans R Soc Lond B Biol Sci (2012) 0.91
Exposure to inflammatory cytokines IL-1β and TNFα induces compromise and death of astrocytes; implications for chronic neuroinflammation. PLoS One (2013) 0.90
Interleukin-1β-induced barrier dysfunction is signaled through PKC-θ in human brain microvascular endothelium. Am J Physiol Cell Physiol (2012) 0.88
Inflammation in neurological and psychiatric diseases. Inflammopharmacology (2012) 0.87
Cerebrospinal fluid biomarker and brain biopsy findings in idiopathic normal pressure hydrocephalus. PLoS One (2014) 0.87
Non-muscle Mlck is required for β-catenin- and FoxO1-dependent downregulation of Cldn5 in IL-1β-mediated barrier dysfunction in brain endothelial cells. J Cell Sci (2014) 0.87
Targeting the neurovascular unit for treatment of neurological disorders. Pharmacol Ther (2010) 0.85
Enteric Glial Cells: A New Frontier in Neurogastroenterology and Clinical Target for Inflammatory Bowel Diseases. Inflamm Bowel Dis (2016) 0.84
Role of ROS and RNS Sources in Physiological and Pathological Conditions. Oxid Med Cell Longev (2016) 0.84
Differentiation of neurons restricts Arbovirus replication and increases expression of the alpha isoform of IRF-7. J Virol (2014) 0.82
Matrix-derived inflammatory mediator N-acetyl proline-glycine-proline is neurotoxic and upregulated in brain after ischemic stroke. J Neuroinflammation (2015) 0.81
Neutralization of TNFSF10 ameliorates functional outcome in a murine model of Alzheimer's disease. Brain (2014) 0.81
Extracellular matrix composition determines astrocyte responses to mechanical and inflammatory stimuli. Neurosci Lett (2015) 0.80
Oxygen radicals elicit paralysis and collapse of spinal cord neuron growth cones upon exposure to proinflammatory cytokines. Biomed Res Int (2014) 0.79
P2X ion channel receptors and inflammation. Purinergic Signal (2016) 0.79
A nonpolar blueberry fraction blunts NADPH oxidase activation in neuronal cells exposed to tumor necrosis factor-α. Oxid Med Cell Longev (2012) 0.79
A narrative review on the similarities and dissimilarities between myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and sickness behavior. BMC Med (2013) 0.79
Alzheimer's and seizures: interleukin-18, indoleamine 2,3-dioxygenase and quinolinic Acid. Int J Tryptophan Res (2010) 0.78
Vamorolone, a dissociative steroidal compound, reduces pro-inflammatory cytokine expression in glioma cells and increases activity and survival in a murine model of cortical tumor. Oncotarget (2016) 0.77
The ns12.9 Accessory Protein of Human Coronavirus OC43 Is a Viroporin Involved in Virion Morphogenesis and Pathogenesis. J Virol (2015) 0.76
Chlamydia pneumoniae infection of monocytes in vitro stimulates innate and adaptive immune responses relevant to those in Alzheimer's disease. J Neuroinflammation (2014) 0.76
Inhibiting High-Mobility Group Box 1 (HMGB1) Attenuates Inflammatory Cytokine Expression and Neurological Deficit in Ischemic Brain Injury Following Cardiac Arrest in Rats. Inflammation (2016) 0.76
Detection of cerebral spinal fluid-associated chemokines in birth traumatized premature babies by chip-based immunoaffinity CE. Electrophoresis (2013) 0.76
Acrolein acts as a neurotoxin in the nigrostriatal dopaminergic system of rat: involvement of α-synuclein aggregation and programmed cell death. Sci Rep (2017) 0.75
Cellular Stress Response and Immune Signaling in Retinal Ischemia-Reperfusion Injury. Front Immunol (2016) 0.75
A Novel Role for Brain Natriuretic Peptide: Inhibition of IL-1β Secretion via Downregulation of NF-kB/Erk 1/2 and NALP3/ASC/Caspase-1 Activation in Human THP-1 Monocyte. Mediators Inflamm (2017) 0.75
Microglia: An Interface between the Loss of Neuroplasticity and Depression. Front Cell Neurosci (2017) 0.75
NADPH Oxidase 2 Regulates NLRP3 Inflammasome Activation in the Brain after Traumatic Brain Injury. Oxid Med Cell Longev (2017) 0.75
Human protein reference database--2006 update. Nucleic Acids Res (2006) 12.16
Two-stage residual inclusion estimation: addressing endogeneity in health econometric modeling. J Health Econ (2007) 5.61
Generalized modeling approaches to risk adjustment of skewed outcomes data. J Health Econ (2005) 4.52
The effect of the Medicare Part D prescription benefit on drug utilization and expenditures. Ann Intern Med (2008) 4.33
Projecting the future diabetes population size and related costs for the U.S. Diabetes Care (2009) 3.34
Minocycline reduces proinflammatory cytokine expression, microglial activation, and caspase-3 activation in a rodent model of diabetic retinopathy. Diabetes (2005) 2.28
Proinflammatory mediators released by activated microglia induces neuronal death in Japanese encephalitis. Glia (2007) 2.04
Japanese encephalitis-a pathological and clinical perspective. PLoS Negl Trop Dis (2009) 1.82
Minocycline neuroprotects, reduces microglial activation, inhibits caspase 3 induction, and viral replication following Japanese encephalitis. J Neurochem (2008) 1.65
Using clinical information to project federal health care spending. Health Aff (Millwood) (2009) 1.62
Multilevel modeling and practice-based research. Ann Fam Med (2005) 1.58
Relationship between quality of care of hospitalized vulnerable elders and postdischarge mortality. J Am Geriatr Soc (2010) 1.56
Health literacy as a predictor of follow-up after an abnormal Pap smear: a prospective study. J Gen Intern Med (2006) 1.55
Inflammation: a new candidate in modulating adult neurogenesis. J Neurosci Res (2008) 1.55
Characteristics of patients receiving pharmaceutical samples and association between sample receipt and out-of-pocket prescription costs. Med Care (2008) 1.48
Synthesis of a novel quinoline derivative, 2-(2-methylquinolin-4-ylamino)-N-phenylacetamide--a potential antileishmanial agent. Bioorg Med Chem (2002) 1.44
The cost-effectiveness of continuous glucose monitoring in type 1 diabetes. Diabetes Care (2010) 1.43
A CTSA agenda to advance methods for comparative effectiveness research. Clin Transl Sci (2011) 1.21
Protective and vulnerability factors predicting new-onset depressive episode in a representative of U.S. adolescents. J Adolesc Health (2008) 1.18
Krüppel-like factor 4, a novel transcription factor regulates microglial activation and subsequent neuroinflammation. J Neuroinflammation (2010) 1.15
Predicting utility ratings for joint health States from single health States in prostate cancer: empirical testing of 3 alternative theories. Med Decis Making (2007) 1.14
Risk stratification for sudden cardiac death: a plan for the future. Circulation (2014) 1.14
Minimal modeling approaches to value of information analysis for health research. Med Decis Making (2011) 1.12
Antiviral and anti-inflammatory effects of rosmarinic acid in an experimental murine model of Japanese encephalitis. Antimicrob Agents Chemother (2007) 1.11
Neuroinflammation and both cytotoxic and vasogenic edema are reduced in interleukin-1 type 1 receptor-deficient mice conferring neuroprotection. Stroke (2005) 1.10
The economics of comparative effectiveness studies: societal and private perspectives and their implications for prioritizing public investments in comparative effectiveness research. Pharmacoeconomics (2010) 1.09
RIG-I mediates innate immune response in mouse neurons following Japanese encephalitis virus infection. PLoS One (2011) 1.07
Modulation of interleukin-1beta mediated inflammatory response in human astrocytes by flavonoids: implications in neuroprotection. Brain Res Bull (2007) 1.05
Induction of IP-10 (CXCL10) in astrocytes following Japanese encephalitis. Neurosci Lett (2007) 1.05
STING mediates neuronal innate immune response following Japanese encephalitis virus infection. Sci Rep (2012) 1.05
Tobacco carcinogen induces microglial activation and subsequent neuronal damage. J Neurochem (2009) 1.04
Critical role of lipid rafts in virus entry and activation of phosphoinositide 3' kinase/Akt signaling during early stages of Japanese encephalitis virus infection in neural stem/progenitor cells. J Neurochem (2010) 1.03
Does competition under Medicare Prospective Payment selectively reduce expenditures on high-cost patients? Rand J Econ (2002) 1.02
The complexity of medication regimens and test ordering for patients with diabetes from 1995 to 2003. Curr Med Res Opin (2007) 1.01
Japanese encephalitis virus induce immuno-competency in neural stem/progenitor cells. PLoS One (2009) 1.01
NLRP3 inflammasome: key mediator of neuroinflammation in murine Japanese encephalitis. PLoS One (2012) 1.01
Understanding the molecular mechanism of blood-brain barrier damage in an experimental model of Japanese encephalitis: correlation with minocycline administration as a therapeutic agent. Neurochem Int (2009) 1.00
Japanese Encephalitis Virus infection induces IL-18 and IL-1beta in microglia and astrocytes: correlation with in vitro cytokine responsiveness of glial cells and subsequent neuronal death. J Neuroimmunol (2008) 0.99
Tumor necrosis factor receptor-1-induced neuronal death by TRADD contributes to the pathogenesis of Japanese encephalitis. J Neurochem (2007) 0.98
Japanese encephalitis virus infection decrease endogenous IL-10 production: correlation with microglial activation and neuronal death. Neurosci Lett (2007) 0.97
Comparative effectiveness research for antipsychotic medications: how much is enough? Health Aff (Millwood) (2009) 0.97
Japanese encephalitis virus infects neural progenitor cells and decreases their proliferation. J Neurochem (2008) 0.96
MicroRNA 155 regulates Japanese encephalitis virus-induced inflammatory response by targeting Src homology 2-containing inositol phosphatase 1. J Virol (2014) 0.96
A common carcinogen benzo[a]pyrene causes neuronal death in mouse via microglial activation. PLoS One (2010) 0.96
Astrogliosis is delayed in type 1 interleukin-1 receptor-null mice following a penetrating brain injury. J Neuroinflammation (2006) 0.95
Antiviral and neuroprotective role of octaguanidinium dendrimer-conjugated morpholino oligomers in Japanese encephalitis. PLoS Negl Trop Dis (2010) 0.95
Abrogated inflammatory response promotes neurogenesis in a murine model of Japanese encephalitis. PLoS One (2011) 0.94
Curcumin protects neuronal cells from Japanese encephalitis virus-mediated cell death and also inhibits infective viral particle formation by dysregulation of ubiquitin-proteasome system. J Neuroimmune Pharmacol (2009) 0.94
Antioxidant potential of Minocycline in Japanese Encephalitis Virus infection in murine neuroblastoma cells: correlation with membrane fluidity and cell death. Neurochem Int (2009) 0.94
Viral infection and neural stem/progenitor cell's fate: implications in brain development and neurological disorders. Neurochem Int (2011) 0.93
Minocycline differentially modulates viral infection and persistence in an experimental model of Japanese encephalitis. J Neuroimmune Pharmacol (2010) 0.93
MicroRNA-29b modulates Japanese encephalitis virus-induced microglia activation by targeting tumor necrosis factor alpha-induced protein 3. J Neurochem (2013) 0.92
Use of minocycline in viral infections. Indian J Med Res (2011) 0.92
Neurons under viral attack: victims or warriors? Neurochem Int (2010) 0.91
Regulatory role of TRIM21 in the type-I interferon pathway in Japanese encephalitis virus-infected human microglial cells. J Neuroinflammation (2014) 0.90
Esophageal replacement in the neonatal period in infants with esophageal atresia and tracheoesophageal fistula. J Pediatr Surg (2007) 0.90
Epigenetic modulation of host: new insights into immune evasion by viruses. J Biosci (2010) 0.90
Novel strategy for treatment of Japanese encephalitis using arctigenin, a plant lignan. J Antimicrob Chemother (2008) 0.89
Tumor necrosis factor receptor-associated death domain mediated neuronal death contributes to the glial activation and subsequent neuroinflammation in Japanese encephalitis. Neurochem Int (2008) 0.89
Visceral leishmaniasis in India: promises and pitfalls of a PCR-based blood test. Trans R Soc Trop Med Hyg (2002) 0.87
Predicting future risk of depressive episode in adolescents: the Chicago Adolescent Depression Risk Assessment (CADRA). Ann Fam Med (2008) 0.87
MicroRNAs in the brain: it's regulatory role in neuroinflammation. Mol Neurobiol (2013) 0.87
Azithromycin in combination with riboflavin decreases the severity of Staphylococcus aureus infection induced septic arthritis by modulating the production of free radicals and endogenous cytokines. Inflamm Res (2012) 0.86
Neural stem cells in the subventricular zone are a source of astrocytes and oligodendrocytes, but not microglia. Dev Neurosci (2003) 0.86
Pre-conditioning induces the precocious differentiation of neonatal astrocytes to enhance their neuroprotective properties. ASN Neuro (2011) 0.86
Fenofibrate reduces mortality and precludes neurological deficits in survivors in murine model of Japanese encephalitis viral infection. PLoS One (2012) 0.85
Epigenetic regulation of self-renewal and fate determination in neural stem cells. J Neurosci Res (2011) 0.85
Japanese encephalitis virus infection modulates the expression of suppressors of cytokine signaling (SOCS) in macrophages: implications for the hosts' innate immune response. Cell Immunol (2013) 0.85
Microglial response to viral challenges: every silver lining comes with a cloud. Front Biosci (Landmark Ed) (2011) 0.85
Ciliary neurotrophic factor and interleukin-6 differentially activate microglia. J Neurosci Res (2008) 0.84
A study of cytokines in tuberculous meningitis: clinical and MRI correlation. Neurosci Lett (2010) 0.84
Astrocytic ceruloplasmin expression, which is induced by IL-1beta and by traumatic brain injury, increases in the absence of the IL-1 type 1 receptor. Glia (2003) 0.83
Chandipura virus induces neuronal death through Fas-mediated extrinsic apoptotic pathway. J Virol (2013) 0.83
Protective effects of interleukin-6 in lipopolysaccharide (LPS)-induced experimental endotoxemia are linked to alteration in hepatic anti-oxidant enzymes and endogenous cytokines. Immunobiology (2009) 0.83
Differential expression of protein tyrosine kinase genes during microglial activation. Glia (2002) 0.83
Health utilities for children and adults with type 1 diabetes. Med Care (2011) 0.83
Cytokines and chemokines in viral encephalitis: a clinicoradiological correlation. Neurosci Lett (2010) 0.83
Therapeutic targeting of Krüppel-like factor 4 abrogates microglial activation. J Neuroinflammation (2012) 0.82
Bispidine-amino acid conjugates act as a novel scaffold for the design of antivirals that block Japanese encephalitis virus replication. PLoS Negl Trop Dis (2013) 0.82
Combination therapy with ampicillin and azithromycin in an experimental pneumococcal pneumonia is bactericidal and effective in down regulating inflammation in mice. J Inflamm (Lond) (2014) 0.82
Japanese encephalitis virus-infected macrophages induce neuronal death. J Neuroimmune Pharmacol (2011) 0.81
Present perspectives on flaviviral chemotherapy. Drug Discov Today (2008) 0.81
Minocycline differentially modulates macrophage mediated peripheral immune response following Japanese encephalitis virus infection. Immunobiology (2009) 0.81
Modeling comparative effectiveness and the value of research. Ann Intern Med (2009) 0.81
Japanese encephalitis virus differentially modulates the induction of multiple pro-inflammatory mediators in human astrocytoma and astroglioma cell-lines. Cell Biol Int (2008) 0.81
A friend in need may not be a friend indeed: role of microglia in neurodegenerative diseases. CNS Neurol Disord Drug Targets (2013) 0.81
Microglia in development and disease. Clin Dev Immunol (2013) 0.80
Cr stable isotopes as indicators of Cr(VI) reduction in groundwater: a detailed time-series study of a point-source plume. Environ Sci Technol (2010) 0.80
Combination therapy with indolylquinoline derivative and sodium antimony gluconate cures established visceral leishmaniasis in hamsters. Antimicrob Agents Chemother (2002) 0.80
Network medicine in drug design: implications for neuroinflammation. Drug Discov Today (2012) 0.80
The prevalence, correlates, and impact of logically inconsistent preferences in utility assessments for joint health states in prostate cancer. Med Care (2011) 0.79
Neuroprotection conferred by astrocytes is insufficient to protect animals from succumbing to Japanese encephalitis. Neurochem Int (2007) 0.79